ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0091

Association of Area-Level Heat and Social Vulnerability with Recurrent Hospitalizations Among Individuals with Rheumatic Conditions

Leah Santacroce, Paul Dellaripa, Karen Costenbader, Jamie collins and Candace Feldman, Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2022

Keywords: Disparities, Environmental factors, Health Services Research, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The neighborhood where a person lives influences health behaviors, access, and outcomes, and contributes to disparities. The relationship between susceptibility to the effects of climate change and acute care utilization among individuals with rheumatic conditions has not been investigated. We examined associations between neighborhood heat and social vulnerability and hospitalizations among individuals with systemic rheumatic conditions, crystalline arthritis, and osteoarthritis.

Methods: Using a Massachusetts (MA) multihospital data repository, we identified individuals ≥18 years with ≥1 ICD-9/10 code for a rheumatic condition who received rheumatology care from 4/1/2018- 4/1/2021 with a valid MA address. We defined the index date as two years before the most recent encounter and the baseline period as one year pre-index date. Addresses were geocoded and linked by census tract to the CDC’s Social Vulnerability Index (SVI) and the Metropolitan Area Planning Council’s Heat Vulnerability Index (HVI). The SVI includes socioeconomic status, household composition, disability, race, ethnicity, language, housing type and transportation. The HVI includes proximity to hazards (heat), socioeconomic, occupational, health and housing conditions. We used multilevel, multinomial logistic regression models to examine the odds of 1-3 and ≥4 hospitalizations (reference = 0) over two years post index date separately by vulnerability index, adjusting for age, gender, race, ethnicity, insurance, and comorbidities. We used multilevel logistic regression models to examine the odds of ≥2 hospitalizations (vs. < 2) by disease category.

Results: Among 14,401 individuals, 11,256 had codes for a systemic rheumatic condition, 1,829 for crystalline arthritis without a systemic condition, and 1,316 for osteoarthritis without a systemic condition or crystalline arthritis. The mean age was 61.9 (SD 15.7) years, 70% were female, 79% White, 7% Black, and 2% Hispanic. 18.8% lived in the highest SVI areas, 11.7% in the highest HVI areas (Figure 1). There were 8,251 hospitalizations; 689 individuals (5%) had ≥4. Accounting for individual-level factors, individuals living in the highest vs. lowest SVI areas had 1.84 times higher odds (95% CI 1.43-2.36) of ≥4 hospitalizations. Individuals living in the highest vs. lowest HVI areas had 1.64 times greater odds (95% CI 1.17-2.31) of ≥4 hospitalizations (Table 1). Black race, male gender, public insurance, and greater comorbidities were associated with recurrent hospitalizations. Significant associations were seen between area vulnerability and recurrent hospitalizations among individuals with systemic rheumatic conditions and crystalline arthritis. (Table 2).

Conclusion: Individuals with systemic rheumatic conditions and crystalline arthritis living in areas with high vs. low social and heat vulnerability had significantly greater odds of recurrent hospitalizations. Identification of neighborhoods where patients with rheumatic conditions are most susceptible to the adverse effects of climate change is critical to develop adaptive and mitigative strategies in the face of the evolving climate emergency.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Santacroce, None; P. Dellaripa, Uptodate, FDA, Genentech, Bristol-Myers Squibb(BMS), Boehringer-Ingelheim; K. Costenbader, Eli Lilly, Janssen, Amgen, AstraZeneca Pharmaceuticals LP, GlaxoSmithKline(GSK), Gilead, Exagen, Neutrolis, Cel-Sci, Alkermes; J. collins, None; C. Feldman, AtlasBio, Pfizer Pharmaceuticals, BMS Foundation, Health Resources in Action, Illumina, Mestag Therapeutics, Elsevier.

To cite this abstract in AMA style:

Santacroce L, Dellaripa P, Costenbader K, collins J, Feldman C. Association of Area-Level Heat and Social Vulnerability with Recurrent Hospitalizations Among Individuals with Rheumatic Conditions [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/association-of-area-level-heat-and-social-vulnerability-with-recurrent-hospitalizations-among-individuals-with-rheumatic-conditions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-area-level-heat-and-social-vulnerability-with-recurrent-hospitalizations-among-individuals-with-rheumatic-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology